DaVita Inc. (DVAI34 SA) stock market data APIs
R$690.1437
0(0%)
as of October 28, 2025
Try our APIs with
free plan!
DaVita Inc. Financial Data Overview
Price chart is built with
Anychart
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Prev. Close
690.1437
Open
690.1437
High
690.1437
Low
690.1437
52 wk Range
677.73-1047.54
Market Cap
49 939 M
P/E Ratio
12.6106
Shares Outstanding
71 500 K
Revenue
13 161 M
Beta
1.124
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get DaVita Inc. data using free add-ons & libraries
Get DaVita Inc. Fundamental Data
DaVita Inc. Fundamental data includes:
- Net Revenue: 13 161 M
- EBITDA: 2 688 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-27
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
DaVita Inc. News
New
Truist Lowers PT on DaVita Inc. (DVA), Keeps a Hold Rating
DaVita Inc. (NYSE:DVA) is one of the Best 52-Week Low Mid Cap Stocks to Buy Now. On October 14, David MacDonald from Truist lowered the firm’s price target on DaVita Inc. (NYSE:DVA) from $148 to ...
Can Technology and Cost Discipline Lift DaVita's Q3 Earnings?
DaVita Inc. DVA is scheduled to report third-quarter 2025 results on Oct. 29, after the closing bell. In the last reported quarter, the company’s earnings per share (EPS) of $2.95 beat the Zacks Co...
VSee Awarded US Department of Health & Human Services FedRAMP High ATO
SAN JOSE, CALIFORNIA / ACCESS Newswire / October 28, 2025 / VSee Health, Inc. (Nasdaq:VSEE) (the "Company"), announced it has received its Authority to Operate (ATO) at the FedRAMP High level from the...
DaVita (DVA) Reports Q3: Everything You Need To Know Ahead Of Earnings
Dialysis provider DaVita Inc. (NYSE:DVA) will be announcing earnings results this Wednesday after market hours. Here’s what investors should know. DaVita beat analysts’ revenue expectations by 0....
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
